The Tim Ferriss Show cover image

The Tim Ferriss Show

#458: The Psychedelic News Hour: New Breakthroughs, Compound Comparisons and Warnings (Psilocybin/LSD/Ayahuasca/N,N-DMT/5-MeO-DMT), Treatment of Trauma, Scalable vs. Unscalable Approaches, Making Sense of “Bad” Trips, and Much More

Sep 3, 2020
In a thought-provoking discussion, Dr. David Rabin, a board-certified psychiatrist and co-founder of Apollo Neuroscience, and Dr. Molly Maloof, a physician and Stanford lecturer, dive into the world of psychedelic-assisted psychotherapy. They explore breakthroughs in treating trauma, emphasizing the importance of a supportive environment. The duo highlights the role of diverse funding in advancing research and the ethical implications within the psychedelic community. They also address coping strategies for challenging trips and the integration of technology in mental health care.
01:38:32

Podcast summary created with Snipd AI

Quick takeaways

  • Challenges in scaling psilocybin therapy include therapist training and safety oversight.
  • Stigma among healthcare professionals impedes mental health support for frontline workers.

Deep dives

Scaling and Impact of Psilocybin Therapy

Scaling psilocybin therapy to reach more individuals presents challenges in training therapists, supervision, and maintaining oversight to ensure safety and success. While the current model involves controlled growth, future expansion is anticipated to increase exponentially, demanding organized efforts to address adverse events, ensure supervision, and prevent backlash.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner